173 related articles for article (PubMed ID: 28597145)
1. Quality of Life, Treatment Beliefs, and Treatment Satisfaction in Children Treated for Primary Immunodeficiency with SCIg.
Sultan S; Rondeau É; Levasseur MC; Dicaire R; Decaluwe H; Haddad É
J Clin Immunol; 2017 Jul; 37(5):496-504. PubMed ID: 28597145
[TBL] [Abstract][Full Text] [Related]
2. Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".
Bienvenu B; Cozon G; Hoarau C; Pasquet M; Cherin P; Clerson P; Hachulla E; Crave JC; Delain JC; Jaussaud R
Orphanet J Rare Dis; 2016 Jun; 11(1):83. PubMed ID: 27334100
[TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life in Adult Patients with Common Variable Immunodeficiency Disorders and Impact of Treatment.
Rider NL; Kutac C; Hajjar J; Scalchunes C; Seeborg FO; Boyle M; Orange JS
J Clin Immunol; 2017 Jul; 37(5):461-475. PubMed ID: 28536745
[TBL] [Abstract][Full Text] [Related]
4. 20% subcutaneous immunoglobulin for patients with primary immunodeficiency diseases: A systematic review.
Song J; Zhang L; Li Y; Quan S; Liang Y; Zeng L; Liu Y
Int Immunopharmacol; 2015 Apr; 25(2):457-64. PubMed ID: 25633961
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
Shapiro RS
Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
[TBL] [Abstract][Full Text] [Related]
6. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.
Gardulf A; Nicolay U; Math D; Asensio O; Bernatowska E; Böck A; Costa-Carvalho BT; Granert C; Haag S; Hernández D; Kiessling P; Kus J; Matamoros N; Niehues T; Schmidt S; Schulze I; Borte M
J Allergy Clin Immunol; 2004 Oct; 114(4):936-42. PubMed ID: 15480339
[TBL] [Abstract][Full Text] [Related]
7. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.
Buysse CM; Raat H; Hazelzet JA; Hop WC; Maliepaard M; Joosten KF
Crit Care Med; 2008 Feb; 36(2):596-602. PubMed ID: 18216608
[TBL] [Abstract][Full Text] [Related]
8. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.
Berger M; Murphy E; Riley P; Bergman GE;
South Med J; 2010 Sep; 103(9):856-63. PubMed ID: 20689467
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency.
Fasth A; Nyström J
Acta Paediatr; 2007 Oct; 96(10):1474-8. PubMed ID: 17850391
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency.
Niebur HB; Duff CM; Shear GF; Nguyen D; Alberdi TK; Dorsey MJ; Sleasman JW
Clin Exp Immunol; 2015 Sep; 181(3):441-50. PubMed ID: 25761372
[TBL] [Abstract][Full Text] [Related]
11. Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G Treatment.
Routes J; Costa-Carvalho BT; Grimbacher B; Paris K; Ochs HD; Filipovich A; Hintermeyer M; de Melo KM; Workman S; Ito D; Ye X; Bonnet P; Li-McLeod J
J Clin Immunol; 2016 Jul; 36(5):450-61. PubMed ID: 27091140
[TBL] [Abstract][Full Text] [Related]
12. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar.
Ehlayel MS; Bener A; Laban MA
J Clin Immunol; 2013 Feb; 33(2):317-24. PubMed ID: 23054346
[TBL] [Abstract][Full Text] [Related]
13. Clinical features that identify children with primary immunodeficiency diseases.
Subbarayan A; Colarusso G; Hughes SM; Gennery AR; Slatter M; Cant AJ; Arkwright PD
Pediatrics; 2011 May; 127(5):810-6. PubMed ID: 21482601
[TBL] [Abstract][Full Text] [Related]
14. Pediatric homeopathy: a prospective observational survey based on parent proxy-reports of their children's health-related Quality of Life in six European countries and Brazil.
Van Wassenhoven M; Goossens M; Anelli M; Sermeus G; Kupers P; Morgado C; Martin E; Bezerra M
Homeopathy; 2014 Oct; 103(4):257-63. PubMed ID: 25439042
[TBL] [Abstract][Full Text] [Related]
15. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06.
Eades-Perner AM; Gathmann B; Knerr V; Guzman D; Veit D; Kindle G; Grimbacher B;
Clin Exp Immunol; 2007 Feb; 147(2):306-12. PubMed ID: 17223972
[TBL] [Abstract][Full Text] [Related]
16. Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program.
Alvarez-Cardona A; Espinosa-Padilla SE; Reyes SO; Ventura-Juarez J; Lopez-Valdez JA; Martínez-Medina L; Santillan-Artolozaga A; Cajero-Avelar A; De Luna-Sosa AR; Torres-Bernal LF; Espinosa-Rosales FJ
J Clin Immunol; 2016 Apr; 36(3):173-8. PubMed ID: 26898367
[TBL] [Abstract][Full Text] [Related]
17. Quality of life impairment in children and adolescents with vitiligo.
Silverberg JI; Silverberg NB
Pediatr Dermatol; 2014; 31(3):309-18. PubMed ID: 24304125
[TBL] [Abstract][Full Text] [Related]
18. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
Pac M
Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland.
Pac M; Bernatowska E
Eur J Pediatr; 2016 Aug; 175(8):1099-105. PubMed ID: 27357411
[TBL] [Abstract][Full Text] [Related]
20. Primary immunodeficiency investigation in patients during and after hospitalization in a pediatric intensive care unit.
Suavinho É; de Nápolis AC; Segundo GR
Rev Paul Pediatr; 2014 Mar; 32(1):32-6. PubMed ID: 24676187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
